Skip to main content


Corporate America Is Sitting on $5 Trillion of M&A Firepower

Wow. Corporate America is sitting on massive amounts of cash that could be unleashed on deals, according to new research from Citi.

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

A steeper fall might cause both buyers and sellers to re-think potential deals, but so far that doesn't seem to be the case yet.

Biotech, pharma stocks tumble amid big market sell-off

Vertex Pharmaceuticals, Amgen and Johnson and Johnson were among the big movers in the biotech and pharmaceutical sectors.

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Celgene says Juno, Impact deals won't be its last

The biopharmaceutical giant's top executive says the company will continue to aggressively invest in R&D and deploy capital to acquire or license assets.

Breaking News

Wells Fargo Stock Lower On Report of Major Mortgage Market Retreat

Wells Fargo could be looking at a major reduction in its once market-leading mortgage business, Bloomberg reported over the weekend.

Is This Synthetic Biology Pioneer On The Right Track?

Amyris is showing progress in one key area, but it may not be enough.

'Pharma Bro' Martin Shkreli's Crypto Conversion Turns Sour

The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.

Over 1.7 Million Fords And Lincolns Are At Risk Of Being Recalled

The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.